Top Markets
Coin of the day
Rafael Holdings, Inc. Rafael Holdings, Inc.

Rafael Holdings, Inc.

RFL
Rang in aandelen #21321
Rafael Holdings, Inc. holds strategic investments in both early-stage and... Rafael Holdings, Inc. holds strategic investments in both early-stage and clinical pharmaceutical companies, alongside a portfolio of commercial real estate assets situated in the United States and Israel. The company's business activities are structured into two primary divisions: Pharmaceuticals and Real Estate. Its Real Estate segment manages and leases a commercial office complex, which features an integrated 800-space public parking facility. The Pharmaceutical division, conversely, focuses on developing and bringing to market therapies designed to capitalize on the metabolic distinctions between healthy cells and malignant ones. The firm's flagship drug candidate is CPI-613 (devimistat), currently undergoing evaluation in numerous clinical trials, including two pivotal Phase III registrational studies for the treatment of advanced pancreatic cancer and relapsed/refractory acute myeloid leukemia. Rafael Holdings, Inc. is headquartered in Newark, New Jersey.
Aandeelprijs
$2.15
Laatst gesynchroniseerd: 2026-08-21
Marktkapitalisatie
$110.06M
Verandering (1 dag)
13.46%
Verandering (1 jaar)
37.76%
Land
US
Handel Rafael Holdings, Inc. (RFL)

Categorie

Aandelsplitsingen voor Rafael Holdings, Inc. (RFL)
Het aandeel Rafael Holdings, Inc. (symbool: RFL) heeft in totaal 0 splitsingen ondergaan.
De meest recente splitsing vond plaats op Aug 23, 2026.
Eén aandeel RFL dat vóór Aug 23, 2026 werd gekocht, staat nu gelijk aan 0 aandelen RFL.
Lijst van aandelen splitsingen
Jaar Splitsing Vermenigvuldiging Cumulatieve vermenigvuldiging
Niet genoeg gegevens voor de verstrekte datums.
Aandelsplitsingen van vergelijkbare bedrijven of concurrenten
Bedrijf Aantal aandelen splitsingen Cumulatieve vermenigvuldiging Land
1 x3
US
0 -
DE
0 -
CN
0 -
DE
0 -
US